My cursor is parked on cell AK-142, and I already know what the number underneath it is going to say before I click. That's what a year of serious data tracking does to a guy; you start reading your own spreadsheet the way I used to read a client's balance sheet, spotting the bad debt before the auditor even opens the file. This particular cell holds my afternoon focus score after two months on a nootropic that was supposed to move the needle on my brain health and my memory both.
It didn't.
Before I go further, here's the paperwork: this site runs on affiliate links, and if you buy something after clicking one, I earn a small commission at no extra cost to you. I only write up nootropics and brain health tools I've actually run through my own tracking sheet — if I can't verify the return myself, it doesn't get a write-up. And I should say plainly, I'm not a doctor or a neuroscientist. I'm a retired accountant with a spreadsheet and a brain that doesn't file paperwork as fast as it used to. Anything that feels like a real medical issue belongs in front of an actual physician, not in my columns.
During one stretch of this hobby, if you can call swallowing horse pills and color-coding rows a hobby, I ran a tighter audit on six leading nootropics back to back. That window alone accounted for something like 130 days of daily entries and well past 400 rows in my tracking tab, plus enough late-night pill sorting that my wife started leaving the Amazon boxes unopened until I finally got to them. What I learned is that this industry runs less on neural chemistry and more on what I'd call creative bookkeeping.
The Premium Nootropic Bottle That Broke My Model
In accounting, a rounding error is the kind of discrepancy you write off because it doesn't move the bottom line. NeuroPrime taught me that in supplement testing, the priciest bottle on the shelf can be exactly that: an expensive rounding error dressed up as a blue-chip investment. I ran it for about three months, tracking daily, and it sat well above everything else in the six-product batch on cost alone.
The marketing promised it would unlock deep neural reserves, which is the kind of phrase that means nothing on an audit and everything on a landing page. Sixty days in, my afternoon focus scores had moved by a margin so small, under 3%, that I couldn't tell it apart from noise in my own data. That's a flatline dressed up as a premium purchase. I wrote the full breakdown, cost against result, line by line, in NeuroPrime for Stress and Focus: My 6-Month Spreadsheet Analysis, and the short version is that paying more bought me a nicer box, not a sharper memory.
Here's the actual criterion I use now, and it would have saved me three months if I'd had it earlier: once a capsule blend crosses a certain price, the returns stop tracking with the cost at all. My subjective memory scores never once climbed more than about 12% above where I started, no matter how premium the bottle looked on the shelf. It's the equivalent of hiring an expensive consulting firm and getting handed a three-page slide deck that just tells you to drink more water.
A Proprietary Blend Hides More Than It Discloses
Somewhere around month four of testing, I started flagging a pattern on labels that read like a category on an old expense report: "Proprietary Blend." In bookkeeping, that's the miscellaneous line, the one where you toss things you'd rather the auditor not itemize. When a bottle lists a "Cognitive Clarity Blend" without breaking out the milligrams of each ingredient, the company is asking you to trust the math without a receipt.
Neuro-Thrive was the clearest example of this from the budget end of the shelf. It's sold as a multi-pack, and on paper it looked like reasonable value. Twelve months of logging told a different story: it held a decent baseline, but it never touched the wall of fog that shows up reliably around three in the afternoon, the same afternoon fog I track separately from morning focus, because the two behave nothing alike on my sheet. Neuro-Thrive is a fine entry-level asset; it just doesn't have the horsepower for a harder audit. I logged the whole twelve months in Improving Working Memory After 50: My 12-Month Neuro-Thrive Data Log.
What I actually look for now, label by label, is whether a company will name its dose. Lion's mane is the one ingredient in this category with real research attached to it — it contains compounds called hericenones, pulled from the fruiting body, and erinacines, from the mycelium, and both have been studied for supporting nerve growth factor activity and for crossing the blood-brain barrier. That's a legitimate mechanism with a name on it. And it's exactly the kind of ingredient a proprietary blend will bury at the bottom of the list in a dose too small to matter, just so it can still appear on the label. My spreadsheet doesn't care what's printed on the bottle. It only cares what shows up in the numbers, and for most of these blends, the numbers didn't move. I kept chasing a real Return on investment on the daily pill ritual, and for a long stretch, the ledger simply refused to balance.
Why I Pivoted From Capsules to Audio Data Tracking
By the far side of that six-product batch, I was ready to clear the whole shelf. Pill fatigue is real. Swallowing six capsules a day only to still lose my car in a parking lot gets old fast, and no spreadsheet column fixes that on its own. So I changed what I was measuring. Instead of testing a chemical input, I started testing the processing side of things, which is how I ended up trying an audio-based program instead of another bottle.
A friend of mine, the one who never misses his Thursday night poker game with his church group, asked me flat out why I was still bothering with any of this. I didn't have a clean answer for him until my wife handed me one by accident. We were splitting a sandwich at Corner Bakery Cafe on Legacy Drive when she mentioned our neighbor's name in passing, a name I hadn't consciously reached for in months, and it came back to me whole, no groping, no static, like it had never actually left.
That happened around week five of running The Brain Song, which isn't a capsule at all; it's an audio program, and it cost a fraction of what I'd already sunk into the premium capsules that went nowhere. My first reaction was skepticism; unregulated audio programs sound like exactly the kind of thing that shouldn't work on paper. But an audit follows the data even when the data surprises the auditor. Over 90 days, my verbal recall numbers jumped further than anything from the pill side of the ledger, somewhere around 22%, against a ceiling of roughly 12% I'd never cleared with capsules, and what I call mental friction, the drag between finishing one task and starting the next, measurably eased. I know some of that could be a placebo baseline doing part of the work, and I'm not going to pretend my tracking sheet rules that out completely. The full numbers are in Does Frequency Beat Formulas? My 56-Day Spreadsheet Analysis of The Brain Song.
It also wasn't the first non-pill thing I'd tried, and it wasn't the first one to disappoint before this one worked. A Lumosity subscription sat on my credit card statement for four months before I finally canceled it; the games got easier over time, sure, but that's the app adapting to me, not my memory getting sharper, and my actual weekly scores barely budged the whole time I paid for it.
It turns out that trimming Cognitive load has less to do with what I swallow and more to do with how the whole system gets tuned. Using an audio tool felt like swapping a paper ledger for cloud accounting software; same underlying job, dramatically less friction in how the data gets processed. I also tracked The Genius Song alongside it, a similar program at a comparable cost, and the results were close enough to call a rounding error in the other direction, in a good way.
How Do You Audit a Brain Health Supplement Label?
If your own shelf is starting to look like mine did around month six, the fix isn't another bottle — it's running your own version of this audit. Start with cost-per-gain instead of cost-per-bottle: work out the daily price against the actual, felt difference, and if you're paying real money for a couple of percentage points, a good cup of coffee is the better trade some days. Then weigh pill fatigue honestly — a high-volume capsule routine you can't sustain past a few weeks is worth zero, no matter what the label promises, which is exactly why I drifted toward the audio side of the shelf; it was simply easier to keep up with daily. And the last check, from a guy who trusts rows and columns more than most people trust their gut: a spreadsheet cannot diagnose anything. Talk to an actual doctor before assuming the hardware needs fixing rather than the software.
Six months of testing has finally given my spreadsheet what I'd call real winners, and I've stopped chasing high-priced capsules like NeuroPrime in favor of cheaper tools that actually move a number. My current rankings and full reviews live in Best Natural Brain Supplements for Concentration: An Accountant's Data. None of this replaces a full supplement ROI breakdown either; that's a separate ledger I keep elsewhere, looking at cost over a full year rather than one testing window, and my actual tracking methodology, the part where I decide what even counts as a "good day" on the sheet, is its own long story for another time.
Your brain is the asset here, not the marketing brochure sitting next to it on the shelf. Audit the claim, track your own result, and cut a product loose the moment the numbers stop supporting it; that's the one lesson that actually transferred out of all this testing and into everything I try next. If you want a place to start that doesn't involve a hundred-plus-dollar bottle, The Brain Song is still the only thing that's paid a consistent cognitive dividend without denting my stomach or my bank account.
I still build spreadsheets for fun, which my wife will tell you is not a normal retirement hobby. At least now I remember which folder I saved the file in. That's a return I can live with.